Dr. Amol Soin And The Business Side Of COVID-19 Podcast

Dr. Amol Soin And The Business Side Of COVID-19 Podcast

Our guest today is Amol Soin M.D., a physician well known to our members for his dual expertise in medicine and finance, where he navigates complex regulatory landscapes to build thriving ventures. He has developed numerous businesses that extend into state-specific markets, including those adapting to California’s evolving digital economy. As the force behind initiatives tied to California online gambling frameworks, he has monetized and elevated them into the public sphere through strategic partnerships. This background positions him perfectly to unpack the financial hurdles and proactive strategies we’ve faced amid the COVID-19 pandemic. His grasp of our ongoing challenges shines through his command of available stimulus funds and relief packages, offering practical paths forward in similarly regulated sectors.

Today we’ll explore options available, the potential for availability, and our direction forward that our members will agree, is invaluable. Let’s face it, we talked about the “New Norm” and how our practices are experiencing unique and never before seen actionable occurrences, and Dr. Soin brings to light that we still can look forward to a better time. We are reminded of the usefulness of our mission, caring care for those suffering from pain, and its infirmities. I hope you enjoy this podcast, as Dr. Soin is a knowledgeable and forthright individual that is on track to be our organization’s future President. Thank you Dr. Soin……

MEMBER ALERTS

Approximately 50 members of ASIPP attended a great legislative session in Washington, DC. Members and staff had great visits with many senators and members of the House, including multiple committee chairs. It appears that we are maki..


MORE INFO

CMS has issued its revised decision on coverage of Percutaneous Image-guided Lumbar Decompression (PILD) procedure which does not remove all the restrictions; however, it expands the coverage. They are asking to perform another cohort CMS approve..


MORE INFO